Sponsor

Region Uppsala

Sweden Storgatan 27, Uppsala Domkyrkofors., 753 31 Uppsala, Sweden

About the sponsor

Region Uppsala supports research in major depressive disorder, psychosis, obsessive-compulsive disorder, and normal pressure hydrocephalus, with additional interest in multiple sclerosis and brain effects linked to hormonal contraception.

Major depression
Psychosis and OCD
Normal pressure hydrocephalus
Multiple sclerosis

Its clinical portfolio includes work on brain function, mood disorders, and immune-related neuropsychiatric conditions.

About Specializations

Region Uppsala runs clinical trials in conditions such as Multiple sclerosis, Major depression, Chronic myeloid leukaemia, Obsessive-compulsive disorder, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

13 clinical trials

Multiple sclerosis

Recruiting

Study of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration

Registered drugNo placebo

Study of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:Aciclovir sodium
Sponsor:Region Uppsala

Contact Research Centre

Major depression

Recruiting

Study of D-cycloserine with theta-burst brain stimulation for adults with major depressive disorder

Investigational

Study of D-cycloserine with theta-burst brain stimulation for adults with major depressive disorder

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Cycloserine
Sponsor:Region Uppsala

Contact Research Centre

A Study of Ciprofloxacin and Vancomycin Effects in Patients Carrying Antibiotic-Resistant Bacteria (ESBL and VRE)

Recruiting

Registered drugNo placebo

A Study of Ciprofloxacin and Vancomycin Effects in Patients Carrying Antibiotic-Resistant Bacteria (ESBL and VRE)

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Ciprofloxacin
Sponsor:Region Uppsala

Contact Research Centre

Chronic myeloid leukaemia

Recruiting

Study on Stopping Dasatinib in Patients with Chronic Myeloid Leukemia After a Previous Attempt to Stop Treatment

Registered drugNo placebo

Study on Stopping Dasatinib in Patients with Chronic Myeloid Leukemia After a Previous Attempt to Stop Treatment

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Dasatinib
Sponsor:Region Uppsala

Contact Research Centre

Obsessive-compulsive disorder+1

Recruiting

Study of Rituximab for Patients with Psychosis or Obsessive-Compulsive Disorder Linked to Immune System Involvement

Registered drugNo placebo

Study of Rituximab for Patients with Psychosis or Obsessive-Compulsive Disorder Linked to Immune System Involvement

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:Rituximab
Sponsor:Region Uppsala

Contact Research Centre

Anaemia

Recruiting

Study on Iron and Mannitol for Anemia Recovery in Patients After Major Surgery with Blood Loss

Registered drugNo placebo

Study on Iron and Mannitol for Anemia Recovery in Patients After Major Surgery with Blood Loss

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Mannitol
Sponsor:Region Uppsala

Contact Research Centre

Hormone-refractory prostate cancer

Not yet recruiting

Phase II Study of Lutetium (177Lu) Zadavotide Guraxetan Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

InvestigationalNo placebo

Phase II Study of Lutetium (177Lu) Zadavotide Guraxetan Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Lutetium (177LU) zadavotide guraxetan
Sponsor:Region Uppsala

Contact Research Centre

Acute kidney injury

Not yet recruiting

Study comparing effects of propofol and sevoflurane on kidney blood flow using magnetic resonance imaging in children at risk of post-operative kidney injury

Registered drugNo placebo

Study comparing effects of propofol and sevoflurane on kidney blood flow using magnetic resonance imaging in children at risk of post-operative kidney injury

Registered drugNo placebo

Sweden

Participants:0–17 years
Substances:Propofol
Sponsor:Region Uppsala

Contact Research Centre

Hormonal contraception

Not recruiting

Study on the Effects of Hormonal Contraceptives on the Brain: Comparing Drospirenone and Estetrol with Ethinylestradiol and Levonorgestrel in Women Using Contraception

Registered drugNo placebo